(2S)-3-[(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methylbut-1-yn-1-yl)-1H-imidazo[4,5-c]pyridin-7-yl]oxy}propyl)amino]propane-1,2-diol

InChIKey	`XMRDIROQMJMYRD-ZDUSSCGKSA-N`
Compound Name	(2S)-3-[(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-4-(3-hydroxy-3-methylbut-1-yn-1-yl)-1H-imidazo[4,5-c]pyridin-7-yl]oxy}propyl)amino]propane-1,2-diol
Canonical SMILES	`CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCCCNC[C@H](O)CO)c21`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	7.43
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P31749	AKT1	Homo sapiens	Human	PF00169 PF00069 PF00433	8.5	IC50	ChEMBL;BindingDB
P31751	AKT2	Homo sapiens	Human	PF00169 PF00069 PF00433	8.3	IC50	ChEMBL;BindingDB
Q13464	ROCK1	Homo sapiens	Human	PF25346 PF00069 PF08912	6.6	IC50	ChEMBL
Q15418	RPS6KA1	Homo sapiens	Human	PF00069 PF00433	6.3	IC50	ChEMBL